Ovarian Cancer Nomogram: Cancer-Specific Survival Following Surgery

Prediction Tools: DisclaimerThe prediction tools, also known as prognostic nomograms, located on the MSK Web site are for general health information only. The prediction tools are not to be used as a substitute for medical advice, diagnosis, or treatment of any health condition or problem.Users of the prediction tools should not rely on information provided by the prediction tools for their own health problems. Questions should be addressed to your own physician or other healthcare provider.MSK makes no warranties, nor express or implied representations whatsoever, regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced in the prediction tools. MSK does not assume any risk whatsoever for your use of the prediction tools or the information contained herein. Health related information changes frequently and therefore information contained in the prediction tools may be outdated, incomplete or incorrect.Use of the prediction tools does not create an express or implied physician-patient relationship. MSK does not endorse or claim validity for the prediction tools found on the MSK Web site. The activities and products of MSK and its developers and agents (collectively MSK) are not endorsed by our past, present, or future employers. MSK does not record specific prediction tool user information and does not contact users of the prediction tools.You are hereby advised to consult with a physician or other professional healthcare provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any healthcare problem or issue you might have at any time, now or in the future. In using the prediction tools, you agree that neither MSK nor any other party is or will be liable or otherwise responsible for any decision made or any action taken or any action not taken due to your use of any information presented in the prediction tools.

Our ovarian cancer nomogram is a tool designed to predict the likelihood of surviving ovarian cancer for five years after surgical treatment for the disease. It is appropriate for patients with any stage of epithelial ovarian cancer who have had surgery (also called debulking or cytoreductive surgery) to remove as much of the cancer as possible.

Results produced by this tool are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of ovarian cancer procedures. All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.

To gather the information required to use this nomogram, use our worksheet.

Enter Your Information

All fields are required unless noted optional

How old were you at the time of your surgery? years (20 to 100)

What was your FIGO tumor stage?

Note: This prediction tool was created using the 1986 FIGO staging system; it applies to stages I to IV. If your pathology report uses a later version with stages that are not included in this drop-down menu, consult with your physician for further guidance on selecting the correct stage.

More on FIGO staging: The FIGO staging system, developed by the International Federation of Gynecology and Obstetrics (FIGO), is used to stage cancers of the cervix, uterus, ovary, vagina, and vulva. It is based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.

What was your albumin level from the blood tests done before your surgery? g/dl (1.5 to 5.5)

What is albumin?: Albumin is a protein made by the liver. A serum albumin test measures the level of albumin in the blood.

What was the maximal diameter of the largest residual tumor remaining after the debulking?

What is debulking?: Debulking refers to the surgical removal of as much of a tumor as possible. Also called tumor debulking.

What was the specific histologic subtype of your ovarian cancer from the pathology report?

What is histology?: Histology refers to the exact type of cancer based on examination of the tumor tissue under the microscope.

What was your ASA score?

What is ASA score?: The ASA score refers to the American Society of Anesthesiologists (ASA) physical status classification system that is used to grade the preoperative physical health of patients who are undergoing surgery.

Do you have a family history suggestive of hereditary breast/ovarian cancer (HBOC) syndrome?

Yes

Note: For patients with a Jewish background, select “yes” if you have a personal or family history of breast cancer, or family history of ovarian cancer. For other patients, select “yes” if you have a personal history of breast cancer, family history of breast cancer before age 50, or ovarian cancer at any age.

What is HBOC syndrome?: Hereditary breast/ovarian cancer (HBOC) syndrome refers to an inherited disorder in which the risk of breast cancer (especially before the age of 50) and ovarian cancer is higher than normal. Most cases of HBOC syndrome are caused by certain mutations (changes) in the BRCA1 or the BRCA2 gene.

Clear